Benson Edagwa

3.4k total citations · 1 hit paper
57 papers, 2.1k citations indexed

About

Benson Edagwa is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Benson Edagwa has authored 57 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 34 papers in Virology and 13 papers in Emergency Medicine. Recurrent topics in Benson Edagwa's work include HIV Research and Treatment (34 papers), HIV/AIDS drug development and treatment (24 papers) and HIV/AIDS Research and Interventions (20 papers). Benson Edagwa is often cited by papers focused on HIV Research and Treatment (34 papers), HIV/AIDS drug development and treatment (24 papers) and HIV/AIDS Research and Interventions (20 papers). Benson Edagwa collaborates with scholars based in United States, Saudi Arabia and Australia. Benson Edagwa's co-authors include Howard E. Gendelman, JoEllyn McMillan, Santhi Gorantla, Bhavesh D. Kevadiya, JoEllyn McMillan, Aditya N. Bade, Yazen Alnouti, Nagsen Gautam, Jonathan Herskovitz and Dhruvkumar Soni and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Nature Materials.

In The Last Decade

Benson Edagwa

56 papers receiving 2.0k citations

Hit Papers

Diagnostics for SARS-CoV-2 infections 2021 2026 2022 2024 2021 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diagnostics for SARS-CoV-2 infections
    2021 585 citations Bhavesh D. Kevadiya, Jatin Machhi et al. Nature Materials profile →

Peers

Benson Edagwa
JoEllyn McMillan United States
Nathalie Dereuddre‐Bosquet France
Fred C. Krebs United States
Raveen Parboosing South Africa
Mark A. Marzinke United States
Craig Sykes United States
Hanping Li China
Krystyna Konopka United States
Yanru Feng China
Jonathan Herskovitz United States
JoEllyn McMillan United States
Benson Edagwa
Citations per year, relative to Benson Edagwa Benson Edagwa (= 1×) peers JoEllyn McMillan

Countries citing papers authored by Benson Edagwa

Since Specialization
Citations

This map shows the geographic impact of Benson Edagwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benson Edagwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benson Edagwa more than expected).

Fields of papers citing papers by Benson Edagwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benson Edagwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benson Edagwa. The network helps show where Benson Edagwa may publish in the future.

Co-authorship network of co-authors of Benson Edagwa

This figure shows the co-authorship network connecting the top 25 collaborators of Benson Edagwa. A scholar is included among the top collaborators of Benson Edagwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benson Edagwa. Benson Edagwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sillman, Brady, Vikas Kumar, Balasrinivasa R. Sajja, et al.. (2023). Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model. Frontiers in Pharmacology. 14. 1294579–1294579. 5 indexed citations
2.
Sillman, Brady, Mahmudul Hasan, Srijanee Das, et al.. (2023). Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection. Advanced Drug Delivery Reviews. 200. 115009–115009. 24 indexed citations
3.
Das, Srijanee, et al.. (2023). Chronic Hepatitis B Infection: New Approaches towards Cure. Biomolecules. 13(8). 1208–1208. 15 indexed citations
4.
Das, Srijanee, Weimin Wang, Murali Ganesan, et al.. (2022). An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science Advances. 8(51). eade9582–eade9582. 11 indexed citations
5.
Alomar, Fadhel A., et al.. (2022). HIV-Tat Exacerbates the Actions of Atazanavir, Efavirenz, and Ritonavir on Cardiac Ryanodine Receptor (RyR2). International Journal of Molecular Sciences. 24(1). 274–274. 4 indexed citations
6.
Gautam, Nagsen, JoEllyn McMillan, Devendra Kumar, et al.. (2021). Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir. Nature Communications. 12(1). 3453–3453. 32 indexed citations
7.
Kevadiya, Bhavesh D., Jatin Machhi, Jonathan Herskovitz, et al.. (2021). Pharmacotherapeutics of SARS-CoV-2 Infections. Journal of Neuroimmune Pharmacology. 16(1). 12–37. 5 indexed citations
8.
Soriano, Vincent, Carmen Alvarez‐Domínguez, Benson Edagwa, et al.. (2021). Ultra-long-acting (XLA) antivirals for chronic viral hepatitis. International Journal of Infectious Diseases. 114. 45–50. 16 indexed citations
9.
Kevadiya, Bhavesh D., Jatin Machhi, Jonathan Herskovitz, et al.. (2021). Diagnostics for SARS-CoV-2 infections. Nature Materials. 20(5). 593–605. 585 indexed citations breakdown →
10.
Gendelman, Howard E., JoEllyn McMillan, Aditya N. Bade, Benson Edagwa, & Bhavesh D. Kevadiya. (2019). The Promise of Long-Acting Antiretroviral Therapies: From Need to Manufacture. Trends in Microbiology. 27(7). 593–606. 26 indexed citations
11.
Edagwa, Benson & Howard E. Gendelman. (2018). Broad-spectrum antivirals. Nature Materials. 17(2). 114–116. 7 indexed citations
12.
Kevadiya, Bhavesh D., Midhun Ben Thomas, Insiya Mukadam, et al.. (2018). Neurotheranostics as personalized medicines. Advanced Drug Delivery Reviews. 148. 252–289. 71 indexed citations
13.
Montenegro-Burke, J. Rafael, Mingliang Fang, Aditya N. Bade, et al.. (2018). Nanoformulated Antiretroviral Therapy Attenuates Brain Metabolic Oxidative Stress. Molecular Neurobiology. 56(4). 2896–2907. 17 indexed citations
14.
Zhang, Wenting, Insiya Mukadam, James R. Hilaire, et al.. (2018). Bioimaging predictors of rilpivirine biodistribution and antiretroviral activities. Biomaterials. 185. 174–193. 27 indexed citations
15.
Zhou, Tianhua, Hang Su, Prasanta K. Dash, et al.. (2017). Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles. Biomaterials. 151. 53–65. 65 indexed citations
16.
Kevadiya, Bhavesh D., Prasanta K. Dash, Balasrinivasa R. Sajja, et al.. (2017). Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution. Theranostics. 8(1). 256–276. 40 indexed citations
17.
Edagwa, Benson, JoEllyn McMillan, Brady Sillman, & Howard E. Gendelman. (2017). Long-acting slow effective release antiretroviral therapy. Expert Opinion on Drug Delivery. 14(11). 1281–1291. 46 indexed citations
18.
Araínga, Mariluz, et al.. (2015). Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy. PLoS ONE. 10(12). e0145966–e0145966. 12 indexed citations
19.
Gendelman, Howard E., Tao Li, Michael D. Boska, et al.. (2015). Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy. International Journal of Nanomedicine. 10. 3779–3779. 19 indexed citations
20.
Edagwa, Benson, et al.. (2014). Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies. Current Medicinal Chemistry. 21(36). 4186–4198. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JoEllyn McMillan Breakdown of academic impact, for papers by Nathalie Dereuddre‐Bosquet Breakdown of academic impact, for papers by Fred C. Krebs Breakdown of academic impact, for papers by Raveen Parboosing Breakdown of academic impact, for papers by Mark A. Marzinke Breakdown of academic impact, for papers by Craig Sykes Breakdown of academic impact, for papers by Hanping Li Breakdown of academic impact, for papers by Krystyna Konopka Breakdown of academic impact, for papers by Yanru Feng Breakdown of academic impact, for papers by Jonathan Herskovitz
Rankless by CCL
2026